Loss Per Share (Tables)

3 Months Ended

Mar. 31, 2025

Antidilutive Securities Excluded from Computation of Earnings Per Share

Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive are as follows:



	March 31, 2025		March 31, 2024
	(shares)		(shares)
Warrants to purchase shares of common stock		9,595,777		9,378,612
Options to purchase shares of common stock		7,999,758		7,402,258
Restricted stock units		536,520		398,000
Shares of common stock issuable upon conversion of convertible notes payable – related party		7,175,772		6,570,108
Shares of common stock issuable upon conversion of convertible line of credit – related party		25,515,956		17,395,464
Shares of common stock issuable upon conversion of preferred stock		499,174		499,174
		51,322,957		41,643,616